Shanghai Bio-heart Biological Technology Co., Ltd. (HKG:2185)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
4.500
+0.030 (0.67%)
Apr 17, 2026, 4:08 PM HKT

HKG:2185 Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,0881,4093998321,4256,598
Market Cap Growth
51.01%253.05%-52.05%-41.56%-78.41%-
Enterprise Value
1,0231,2681324587276,189
Last Close Price
4.475.791.643.425.8427.05
PS Ratio
21.7628.19----
PB Ratio
1.602.070.550.981.385.19
P/TBV Ratio
5.967.720.991.622.107.53
EV/Sales Ratio
20.4625.36----
Debt / Equity Ratio
0.020.020.010.000.020.02
Net Debt / Equity Ratio
-0.38-0.38-0.28-0.47-0.47-0.66
Net Debt / EBITDA Ratio
3.633.633.582.481.831.71
Net Debt / FCF Ratio
--1.165.512.545.59
Asset Turnover
0.060.06----
Inventory Turnover
0.830.83----
Quick Ratio
10.8010.8010.3018.7115.8519.49
Current Ratio
15.2615.2615.2220.3518.7720.55
Return on Equity (ROE)
-10.59%-10.59%-12.83%-22.36%-23.68%-46.08%
Return on Assets (ROA)
-5.72%-5.72%-4.92%-11.44%-15.04%-26.95%
Return on Capital Employed (ROCE)
-8.90%-8.90%-8.50%-20.60%-26.50%-38.00%
Earnings Yield
-7.16%-5.53%-23.44%-23.28%-16.21%-6.72%
FCF Yield
---44.44%-8.83%-13.54%-2.28%
Buyback Yield / Dilution
---0.14%-10.50%-61.54%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.